Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

NCT01044303 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Transplant; Failure, Kidney

Interventions

DRUG: Myfortic Escalation

Sponsor

East Carolina University

Collaborators

[object Object]